✦ New CED Clinical Relevance #82High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Hemp RegulationProduct QualityPatient AccessPolicyDelta-8 Thc Why This MattersRegulatory changes in hemp-derived THC products...
Kansas smoke shops sue state alleging illegal search and seizure during THC raids
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Hemp ProductsLegal FrameworkPatient AccessDelta-8 ThcRegulatory Compliance Why This MattersLegal uncertainties around hemp-derived products create...
Indiana hemp drug ban, early voting restrictions die at deadline
WHY IT MATTERS: If you are an Indiana resident currently using hemp-derived THC products for symptom management, your access remains unchanged for now, but you should still exercise caution because these products remain largely unregulated for potency, purity, and accurate labeling. CLINICAL OVERVIEW: Indiana’s proposed ban on intoxicating hemp-derived THC products failed to advance before a legislative deadline, leaving the current market for these products intact for now. This outcome means that consumers in Indiana will continue to have access to hemp-derived THC products that exist in a regulatory gray area under the 2018 Farm Bill, though the lack of comprehensive regulation also means product safety and labeling standards remain inconsistent.